Aimei Health Technology Co., Ltd.

Aimei Health Technology Co., Ltd., trading on Nasdaq under the ticker AFJK, is a health technology company that entered U.S. public markets through a SPAC transaction. The company filed an 8-K current report with the SEC on September 3, 2026, under accession number 0001493152-26-041316, signaling a material disclosure event. Operating in the health technology sector, Aimei Health Technology represents the growing wave of Asia-based healthcare and digital-health businesses accessing U.S. capital markets via the blank-check vehicle structure. For complete filing history, sponsor details, deal terms, and real-time status updates on AFJK and thousands of other SPAC transactions, sign up for full data access at SpacDesk.